Alchemab Therapeutics
VIVO
27,000
Completed
27,000 SF that includes half core and shell lab and half basic lab space. Alchemab a biotechnology company developing novel products by harnessing the natural protective power of the human immune system, identifying antibodies through patient sample analysis.
Âé¶¹ÍøÕ¾ is committed to building strong, long-lasting client relationships, and to consistently delivering solutions that exceed expectations. Contact us today about starting your next project.